Noah Auerhahn
Founder/CEOSerial Entrepreneur Building Therapies and New Biz Models for Rare Disease
Browser storage is unavailable. Keep this page open and export your collection before leaving.

Our founder Noah, an experienced tech entrepreneur, was directly impacted by a severe genetic disease when his daughter was diagnosed with Rett Syndrome, a disease that afflicts 1 in 10,000 girls. Using an innovative polytherapy strategy, we’ve successfully improved her quality of life, and have designed new therapeutics that each could be worth bi
Our founder Noah, an experienced tech entrepreneur, was directly impacted by a severe genetic disease when his daughter was diagnosed with Rett Syndrome, a disease that afflicts 1 in 10,000 girls. Using an innovative polytherapy strategy, we’ve successfully improved her quality of life, and have designed new therapeutics that each could be worth billions and together could deliver a cure.
Serial Entrepreneur Building Therapies and New Biz Models for Rare Disease
Biotech entrepreneur and biomedical scientist specializing in modeling neurological disorders using stem cells, in vivo models, and computational biology to drive breakthroughs in neurological diseases
Founded 2024 · Source
Source-based assessment · automated evidence rules
The retained text does not establish product availability or customer use.
Maturity is an evidence-based assessment, not a success rating. It may understate the current stage where evidence is limited. Coverage records documented areas, not a complete or independently audited company history.